Aviptadil, a combination of synthetic vasoactive intestinal polypeptide (VIP) (~28 amino acids) and phentolamine, is approved in Europe for the treatment of erectile dysfunction [51]. The gene discussed is VIP; the disease is erectile dysfunction.